|
Invited Speakers:
|
|
Dr Gvido Cebers, Senior Project Director, Lead Toxicologist, AstraZeneca
Dr Stefan Scherer, Global Biomarker Head, Roche
Dr Andreas Wallnoefer, Senior VP, Global Head of Clinical Development Metabolic and Neuroscience, Roche
Dr Nigel Dallow, Director Clinical Statistics, GSK
Dr David Elder, Director of Product Development, GSk
Dr Brian Henry, Exec Director, Pharmaceutical Research and Development, Pfizer
Dr Lewis Kinter, Senior Director- Regulatory Toxicology, AstraZeneca
Dr Ines Paule, Modeling and Simulation Scientist, Clinical Pharmacology, Actelion
|
|